{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T04:28:48Z","timestamp":1782016128814,"version":"3.54.5"},"reference-count":80,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T00:00:00Z","timestamp":1391040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0086941","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T17:15:47Z","timestamp":1391102147000},"page":"e86941","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["Neoadjuvant Chemotherapy Followed by Surgery versus Surgery Alone for Gastric Carcinoma: Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1371","volume":"9","author":[{"given":"A-Man","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Xiu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"R Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"A Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"J Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"A Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ejca.2008.11.018","article-title":"EUROCARE-4. Survival of cancer patients diagnosed in 1995\u20131999. Results and commentary","volume":"45","author":"M Sant","year":"2009","journal-title":"Eur J Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"JS Macdonald","year":"2001","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"v50","DOI":"10.1093\/annonc\/mdq164","article-title":"Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21 Suppl 5","author":"A Okines","year":"2010","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","article-title":"Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial","volume":"29","author":"M Ychou","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrclinonc.2012.23","article-title":"Gastrointestinal cancer: Adjuvant chemotherapy after D2 gastrectomy for gastric cancer","volume":"9","author":"T Yoshikawa","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10120-011-0042-4","article-title":"Japanese gastric cancer treatment guidelines 2010 (ver. 3)","volume":"14","author":"A Japanese Gastric Cancer","year":"2011","journal-title":"Gastric Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","article-title":"Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial","volume":"379","author":"YJ Bang","year":"2012","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","article-title":"Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer","volume":"29","author":"M Sasako","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.2010.534","article-title":"Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis","volume":"303","author":"G Group","year":"2010","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1989.7.9.1318","article-title":"Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin","volume":"7","author":"H Wilke","year":"1989","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/bjs.6665","article-title":"Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer","volume":"96","author":"T Yoshikawa","year":"2009","journal-title":"Br J Surg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10120-008-0496-1","article-title":"Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002)","volume":"12","author":"T Kinoshita","year":"2009","journal-title":"Gastric Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/jgh.12152","article-title":"Neoadjuvant chemotherapy for gastric cancer: a meta-analysis of randomized, controlled trials","volume":"28","author":"Y Liao","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.3748\/wjg.v18.i48.7384","article-title":"Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric\/gastroesophageal cancer: a meta-analysis","volume":"18","author":"L Ge","year":"2012","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.3748\/wjg.v16.i44.5621","article-title":"Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis","volume":"16","author":"W Li","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref20","first-page":"CD005047","article-title":"Neoadjuvant chemotherapy versus none for resectable gastric cancer","author":"AW Wu","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF01658939","article-title":"Neoadjuvant chemotherapy for high-grade advanced gastric cancer","volume":"17","author":"Y Yonemura","year":"1993","journal-title":"World J Surg"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.3748\/wjg.v10.i20.3070","article-title":"Clinical significance of preoperative regional intra-arterial infusion chemotherapy for advanced gastric cancer","volume":"10","author":"CW Zhang","year":"2004","journal-title":"World J Gastroenterol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"D Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"ref24","first-page":"2035","article-title":"Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial","volume":"46","author":"NJ Lygidakis","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"DF Stroup","year":"2000","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"D Moher","year":"2009","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"A Liberati","year":"2009","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","article-title":"Japanese classification of gastric carcinoma: 3rd English edition","volume":"14","author":"A Japanese Gastric Cancer","year":"2011","journal-title":"Gastric Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1158\/1078-0432.CCR-10-2203","article-title":"Molecular classification of gastric cancer: a new paradigm","volume":"17","author":"MA Shah","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/annonc\/mdn716","article-title":"The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma\u2013individual patient data from 1775 patients in four randomised controlled trials","volume":"20","author":"I Chau","year":"2009","journal-title":"Ann Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"SP Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"AR Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"D Moher","year":"1998","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(00)04934-5","article-title":"Bringing it all together: Lancet-Cochrane collaborate on systematic reviews","volume":"357","author":"M Clarke","year":"2001","journal-title":"Lancet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"JP Higgins","year":"2002","journal-title":"Stat Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"P Macaskill","year":"2001","journal-title":"Stat Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jclinepi.2010.11.016","article-title":"A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners","volume":"64","author":"DJ Fisher","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"ref41","first-page":"473","article-title":"Preoperative superselective intraarterial chemotherapy in the combined treatment of gastric-carcinoma","volume":"2","author":"I Shchepotin","year":"1995","journal-title":"Oncol Rep"},{"key":"ref42","unstructured":"Kang YK, Choi DW, Im YH, Kim CM, Lee JI, <etal>et al<\/etal>.. (1996) A phase III randomized comparison of neoadjuvant chemotherapy followed by surgery versus surgery for locally advanced stomach cancer. Abstract 503 presented at the ASCO Annual Meeting. ASCO website. Available: URL: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.asco.org\/ASCOv2\/Meetings\/Abstracts?&vmview=abst_detail_view&confID=29&abstractID=10042\" xlink:type=\"simple\">http:\/\/www.asco.org\/ASCOv2\/Meetings\/Abstracts?&amp;vmview=abst_detail_view&amp;confID=29&amp;abstractID=10042<\/ext-link>. Accessed 2013 July 26."},{"key":"ref43","first-page":"1521","article-title":"Long-term outcome of preoperative chemotherapy with 5\u2032-deoxy-5-fluorouridine (5\u2032-DFUR) for gastric cancer","volume":"27","author":"T Kobayashi","year":"2000","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref44","first-page":"241","article-title":"A favorable impact of preoperative FPLC chemotherapy on patients with gastric cardia cancer","volume":"7","author":"XL Wang","year":"2000","journal-title":"Oncol Rep"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ejso.2004.04.013","article-title":"Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial","volume":"30","author":"HH Hartgrink","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"ref46","first-page":"1879","article-title":"A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer\u2013a single institute study","volume":"24","author":"Y Nio","year":"2004","journal-title":"Anticancer Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3748\/wjg.v12.i9.1356","article-title":"Apoptosis induced by preoperative oral 5\u2032-DFUR administration in gastric adenocarcinoma and its mechanism of action","volume":"12","author":"WH Zhao","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ejso.2010.06.012","article-title":"Prospective randomized trial of short-term neoadjuvant chemotherapy for advanced gastric cancer","volume":"36","author":"M Imano","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1200\/JCO.2009.26.6114","article-title":"Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954","volume":"28","author":"C Schuhmacher","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00432-008-0425-z","article-title":"Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction","volume":"135","author":"M Menges","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00423-010-0738-7","article-title":"Gastric cancer: surgery in 2011","volume":"396","author":"K Ott","year":"2011","journal-title":"Langenbecks Arch Surg"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10120-012-0156-3","article-title":"Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study","volume":"15","author":"Y Kodera","year":"2012","journal-title":"Gastric Cancer"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00280-010-1432-8","article-title":"Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer","volume":"67","author":"D Takahari","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10120-010-0559-y","article-title":"A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703)","volume":"13","author":"Y Kodera","year":"2010","journal-title":"Gastric Cancer"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejso.2011.11.009","article-title":"Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer","volume":"38","author":"K Inoue","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"ref56","first-page":"4689","article-title":"Preoperative chemotherapy with S-1 and cisplatin for highly advanced gastric cancer","volume":"29","author":"A Nashimoto","year":"2009","journal-title":"Anticancer Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ejso.2010.04.011","article-title":"A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2\/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study)","volume":"36","author":"T Yoshikawa","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10120-009-0505-z","article-title":"Paclitaxel chemotherapy for the treatment of gastric cancer","volume":"12","author":"J Sakamoto","year":"2009","journal-title":"Gastric Cancer"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10120-011-0124-3","article-title":"A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer","volume":"15","author":"K Nishikawa","year":"2012","journal-title":"Gastric Cancer"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00280-013-2130-0","article-title":"Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer","volume":"71","author":"A Tsuburaya","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref61","first-page":"2205","article-title":"Multimodal therapy in locally advanced gastric cancer","volume":"136","author":"E Bolke","year":"2011","journal-title":"Dtsch Med Wochenschr"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/bcr2227","article-title":"Recent advances in systemic therapy: advances in neoadjuvant (primary) systemic therapy with cytotoxic agents","volume":"11","author":"M Untch","year":"2009","journal-title":"Breast Cancer Res"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"e53403","DOI":"10.1371\/journal.pone.0053403","article-title":"Clinical efficacy of including capecitabine in neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Q Li","year":"2013","journal-title":"PLoS One"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"e45388","DOI":"10.1371\/journal.pone.0045388","article-title":"P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer","volume":"7","author":"MB Chen","year":"2012","journal-title":"PLoS One"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"e39655","DOI":"10.1371\/journal.pone.0039655","article-title":"Value of TP53 status for predicting response to neoadjuvant chemotherapy in breast cancer: a meta-analysis","volume":"7","author":"MB Chen","year":"2012","journal-title":"PLoS One"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4240\/wjgs.v4.i2.27","article-title":"Neoadjuvant chemotherapy for locally advanced gastric cancer: With or without radiation","volume":"4","author":"AW Wu","year":"2012","journal-title":"World J Gastrointest Surg"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jso.22085","article-title":"Clinicopathologic variables predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer","volume":"105","author":"LB Wang","year":"2012","journal-title":"J Surg Oncol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1200\/JCO.1997.15.1.261","article-title":"Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer","volume":"15","author":"A Webb","year":"1997","journal-title":"J Clin Oncol"},{"key":"ref69","first-page":"CD004064","article-title":"Chemotherapy for advanced gastric cancer","author":"AD Wagner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1245\/s10434-012-2817-1","article-title":"A prospective validation study to diagnose serosal invasion and nodal metastases of gastric cancer by multidetector-row CT","volume":"20","author":"S Hasegawa","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jss.2012.04.062","article-title":"Does neoadjuvant chemotherapy improve outcomes for patients with gastric cancer?","volume":"178","author":"S Misra","year":"2012","journal-title":"J Surg Res"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000328746","article-title":"A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer","volume":"80","author":"H Iwase","year":"2011","journal-title":"Oncology"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00280-010-1353-6","article-title":"Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer","volume":"67","author":"JY Kim","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00280-009-1215-2","article-title":"Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer","volume":"66","author":"Y Sato","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00280-011-1701-1","article-title":"A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)","volume":"69","author":"W Koizumi","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s10120-009-0521-z","article-title":"Docetaxel: its role in current and future treatments for advanced gastric cancer","volume":"12","author":"M Nishiyama","year":"2009","journal-title":"Gastric Cancer"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jjco\/hyp178","article-title":"A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized Phase II trial (COMPASS)","volume":"40","author":"T Yoshikawa","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/jjco\/hyr183","article-title":"Phase II trial of preoperative chemotherapy with docetaxel, cisplatin and S-1 for T4 locally advanced gastric cancer","volume":"42","author":"S Fushida","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"ref79","first-page":"868","article-title":"Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer","volume":"16","author":"R Biffi","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/1471-2407-11-329","article-title":"Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)","volume":"11","author":"JL Dikken","year":"2011","journal-title":"BMC Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0086941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:55:27Z","timestamp":1589021727000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0086941"}},"subtitle":[],"editor":[{"given":"Tone Frost","family":"Bathen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,30]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0086941","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718266360.793490797","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,30]]}}}